We find that BRCA1/2 loss-of-function mutations – when present in both alleles or when coupled with LOH – are associated with the same HR deficiency associated mutational signatures as are present in BRCA1/2-mutant ovarian, breast, or prostate tumors. Here, BRCA1 is linked to prostate neoplasm.